Polycythaemia vera resources for you and your patients
Explore our range of PV resources developed for both healthcare professionals and patients with PV. New resources are being added, so please visit regularly to keep up to date.
Hydroxyurea Intolerance and Resistance Guide
Hydroxyurea Intolerance and Resistance Guide
The signs and symptoms of HU intolerance and resistance, and the importance of recognising it quickly.
These resources have been developed by Novartis and are intended for patients who have been diagnosed with an MPN. These resources will help give patients the confidence and knowledge to discuss their disease and track symptoms effectively. Information provided in these resources should not be considered an alternative to advice from a healthcare professional. Please do not direct patients to this page. Patient resources should be downloaded and forwarded to your patients. Alternatively, you can request hard copies from your local representative.
Hydroxyurea is synonymous with/refers to hydroxycarbamide throughout.
HU, hydroxyurea; MPN, myeloproliferative neoplasm; PV, polycythaemia vera.
UK | February 2025 | FA-11213885
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report, or alternatively email [email protected] or call 01276 698370.
